Apr 17, 2024

Autism Tsunami: The Cost of the Aging Autism Population

On ‘Defender In-Depth’ this week:

  • How Big Pharma and private equity funds see autism treatment as a ‘market opportunity’
  • Efforts being undertaken by parents of kids with neurological disorders
  • Autism’s future costs
  • WHO's proposals, AI and the their relationship to neurological disorders
  • Current infrastructure for supporting the autism community
  • Other similar initiatives to set up care communities/future housing for people with autism

Watch the episode on CHD.TV!

*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.

DonateFree Sign-Up


FDA Says 'No Safety Signals' Linking White Blood Clots to COVID Shots, Despite Embalmer Survey Suggesting Otherwise

CHD Files FOIA Requests: Why Did Government Shut Down Studies on Cellphone Radiation and Cancer?

Is the WEF's Metaverse Just an 'Enforcement Regime' for Vaccination?

Pfizer's Misleading COVID Vaccine Claims 'Brought Discredit' on Big Pharma, UK Regulator Finds

'Low Credibility' Study Claims No Link Between Cellphone Use and Brain Tumors

Pfizer Seeks FDA Approval for RSV Vaccine for Young Adults, Is Also Conducting RSV Trial for Kids as Young as 2

'Autism Tsunami': Society's Cost to Care for Expanding, Aging Autism Population Will Hit $5.54 Trillion by 2060

'Heartbreaking': Pharma Eyes Exponential Growth in Multi-Billion Market for Autism Drugs

Vaccine Safety in 2023 - Where Have all the Critical Thinkers Gone?

HRSA | VICP Data and Statistics

Thousands of Mass. Children Diagnosed With Autism Are Becoming Adults. Many Families Find the State Unprepared to Help. | MSN

Age of Autism | Website

Report of the Review Committee Regarding Amendments to the International Health Regulations (2005) | PDF

Hiding Behind Genetics to Avoid Culpability for Environmental Causes of Autism

'Whole Thing Smacks of a Brave New World': New AI Tool Predicts Vaccine Hesitancy

Childhood Vaccine Schedule Led to 'Greatest Decline in Public Health in Human History'

Huge Untapped Demand in the $4+ Billion U.S. Autism Treatment Centers Market

Prevalence of Autism Spectrum Disorder Among Children and Adolescents in the United States From 2019 to 2020

J&J Uses 'Rare' Legal Challenge in Bid to Delay Lawsuits Alleging Tylenol Caused Autism

J.&J. to Pay $2.2 Billion in Risperdal Settlement (Published 2013)

Related Videos